Roche Holding Ltd

ROG

Equity

ISIN CH0012032048 / Valor 1203204

SIX Swiss Exchange (2026-08-26)

CHF 368.30-1.47%

Roche Holding Ltd
UMushroom community rating:

4.41 44 votes No rating yet

NegativeNeutralPositive

About company

Roche Holding Ltd is a Swiss multinational healthcare company headquartered in Basel that operates primarily through two businesses: Pharmaceuticals and Diagnostics. The Pharmaceuticals division develops and commercializes prescription medicines—particularly biologics and targeted therapies—across oncology, immunology, infectious diseases, neuroscience and ophthalmology, and includes the majority-owned US biotech unit Genentech; several well-known oncology drugs in its portfolio have driven its commercial profile. The Diagnostics division supplies laboratory and point-of-care instruments, reagents and software for clinical chemistry, molecular diagnostics, tissue-based cancer testing and diabetes care (including blood‑glucose systems), serving hospitals, clinical labs and blood‑screening organizations worldwide. Roche is research-intensive, invests heavily in R&D and in partnerships or acquisitions with other biotech firms to advance targeted and personalized medicine, and is publicly listed with a broad global commercialization and distribution footprint.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

42.1%1Y

42.1%3Y

0.70%5Y

Performance

24.6%1Y

22.1%3Y

20.8%5Y

Volatility